Il est connu que l’exposition au tétrachlorure de carbone et au sulfure de carbone peut s’accompagner de douleurs diffuses.
1Goldberg RJ, Novack DH, Gask L. The recognition and management of somatization. What is needed in primary care training ? Psychosomatics 1992 ; 33 : 55-61.
2Kroenke, K, Price, RK. Symptoms in the community. Prevalence, classification, and psychiatric comorbidity. Arch Intern Med 1993 ; 153 : 2474.
3Katon, WJ, Walker, EA. Medically unexplained symptoms in primary care. J Clin Psychiatry 1998 ; 59(Suppl 20) :15.
4Smith GR. The course of somatization and its effects on utilization of health care resources. Psychosomatics 1994 ; 35 : 263-7.
5Fink P. The use of hospitalizations by persistent somatizing patients. Psychol Med 1992; 22 : 173-80.
6Twemlow SW, Bradshaw SL Jr, Coyne L, Lerma BH. Patterns of utilization of medical care and perceptions of the relationship between doctor and patient with chronic illness including chronic fatigue syndrome. Psychol Rep 1997 ; 80 : 643-58.
7Sharpe M, Mayou R, Seagroatt V, et al. Why do doctors find some patients difficult to help ? Q J Med 1994 ; 87 : 187-93.
8 Mayou R. Professor, a Michael Sharpe Editorials : Treating medically unexplained physical symptoms. BMJ 1997 ; 315 : 561-2.
9 Demondion B, Huguet A, Patrouillault C. Les troubles somatoformes : de la nécessité d’une prise en charge adaptée. Rev Med Ass Maladie 2000 ; 1 : 7-13.
10Smith R, Lyles J, Gardiner JC, et al. Primary care clinicians treat patients with medically unexplained symptoms : A randomized controlled trial. J Gen Intern Med 2006 ; 21 ; 671-7.
11Fink P. Surgery and medical treatment in persistent somatizing patients. J Psychosom Res 1992 ; 36 : 439-47.
12Mayou R, Sharpe M. Treating medically unexplained physical symptoms. BMJ 1997 ; 315 : 561-2.
13Smith GR Jr, Monson RA, Ray DC. Psychiatric consultation in somatization disorder. A randomized controlled study. N Engl J Med 1986 ; 314 : 1407-13.
14Smith GR Jr, Rost K, Kashner TM. A trial of the effect of a standardized psychiatric consultation on health outcomes and costs in somatizing patients Arch Gen Psychiatry 1995 ; 52 : 238-43.
15Ring A, Dowrick CF, Humphris GM, Davies J, Salmon P. The somatising effect of clinical consultation : What patients and doctors say and do not say when patients present medically unexplained physical symptoms. Soc Sci Med 2005 ; 61 : 1505-15.
16Salmon P, Ring A, Dowrick CF, Humphris GM. What do general practice patients want when they present medically unexplained symptoms, and why do their doctors feel pressurized. J Psychosom Res 2005 ; 59 : 255-60.
17Salmon P, Peters S, Stanley I. Patients’ perceptions of medical explanations for somatisation disorders : Qualitative analysis. BMJ 1999 ; 318 : 372-6.
18Barsky AJ, Ahern DK. Cognitive Behavior Therapy for Hypochondriasis : A Randomized Controlled Trial. JAMA 2004 ; 291 : 1464-70.
19Rost K, Kashner TM, Smith GR Jr. Effectiveness of psychiatric intervention with somatization disorder patients : Improved outcome at reduced costs. Gen Hosp Psychiatry 1994 ; 16 : 379-80.
20Speckens AEM, Van Hemert AM, Spinhoven P, et al. Cognitive behavioural therapy for medically unexplained physical symptoms : A randomised controlled trial. BMJ 1995 ; 311 : 1328-32.
21Hellman CJ, Budd M, Borysenko J, McClelland DC, Benson H. A study of the effectiveness of two group behavioral medicine interventions for patients with psychosomatic complaints. Behav Med 1990 ; 16: 165-73.
22Smith R, Lyles J, Gardiner JC et al. Primary care clinicians treat patients with medically unexplained symptoms : A randomized controlled trial. J Gen Intern Med 2006 ; 21 ; 671-7.
23Smith RC, Lein C, Collins C, et al. Treating patients with medically unexplained symptomes in primary care. J Gen Intern Med 2003 ; 18 : 478-89.
24Smith RC, Lyles JS, Mettler J, Stoffelmayr BE, et al. The effectiveness of intensive training for residents in interviewing. A randomized, controlled study. Ann Intern Med 1998 ; 128 : 118-26.
25Whiting P, Bagnall AM, Snowden AJ, et al. Interventions for the traitement and mangament of chronic fatigue syndrome-asystematic review. JAMA 2001 ; 286 : 1360-8.
26Sharpe M, Hawton K, Simkin S, et al. Cognitive behaviour therapy for the chronic fatigue syndrome : A randomised controlled trial. BMJ 1996 ; 312 : 22-6.
27Clark DM, Salkovskis PM, Hackmann A, Wells A, Ludgate J, Gelder M. Brief cognitive therapy for panic disorder : A randomized controlled trial. J Consult Clin Psychol 1999 ; 67 : 583-9.
28Potts SG, Bass CM. Psychosocial outcome and use of medical resources in patients with chest pain and normal or near-normal coronary arteries : A long-term follow-up study. Q J Med 1993 ; 86 : 583-93.
29Heymann-Monnikes I, Arnold R, Florin I, Herda C, Melfsen S, Monnikes H. The combination of medical treatment plus multicomponent behavioral therapy is superior to medical treatment alone in the therapy of irritable bowel syndrome. Am J Gastroenterol 2000 ; 95 : 981-94.
30Barsky AJ, Borus JF. Functional somatic syndromes. Ann Intern Med 1999 ; 130 : 910-21.
31Salmon P, Peters S, Stanley I. Patients’ perceptions of medical explanations for somatisation disorders : Qualitative analysis. BMJ 1999 ; 318 : 372-6.
32Kouyanou K, Pither CE, Wessely S. Iatrogenic factors and chronic pain. Psychosom Med 1997 ; 59 : 597-604.
33Barsky AJ, Bailey ED, Fama JM, Ahern DK. Predictors of remission in DSM hypochondriasis. Compr Psychiatry 2000 ; 41 : 179-83.
34Salmon P, Peters S, Stanley I. Patients’ perceptions of medical explanations for somatisation disorders : Qualitative analysis. BMJ 1999 ; 318 : 372-6.
35Carette S, Bell MJ, Reynolds WJ, et al. Amitriptylline or cyclobenzaprine provided short-term benefit for fibromyalgia. Arthritis Rheum 1994 ; 37 : 32-40.
36Itman FG, Linssen AC, Edelbroek PM, Van Kempen GM. Does addition of low-dose flupentixol enhance the analgetic effects of low-dose amitriptylline in somatoform pain disorder ? Pain 1991 ; 47 : 25-30.